Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.1950 (0.44%) ($9.1950 - $9.1950) on Wed. Dec. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.67% (three month average) | RSI | 42 | Latest Price | $9.1950(0.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -2.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(57%) IWC(53%) IWO(49%) IWM(48%) IWN(46%) | Factors Impacting EDIT price | EDIT will decline at least -2.335% in a week (0% probabilities). VIXM(-12%) XBI(-9%) VXX(-9%) XME(-6%) URA(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.335% (StdDev 4.67%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.71(-81.4%) | Resistance Level | $9.86 | 5 Day Moving Average | $9.55(-3.72%) | 10 Day Moving Average | $9.69(-5.11%) | 20 Day Moving Average | $9.86(-6.74%) | To recent high | -34% | To recent low | 0.7% | Market Cap | $571m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |